Prevention of recurrent calcium nephrolithiasis

Nephrology

Volumn 12, Issue SUPPL. 1, 2007, Pages

  Kairaitis, Lukas ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; BICARBONATE; CALCIUM; CHLORTALIDONE; CITRIC ACID; INDAPAMIDE; MAGNESIUM; PHOSPHATE; PLACEBO; POTASSIUM; THIAZIDE DIURETIC AGENT; TRICHLORMETHIAZIDE;

BLOATING; CALCIUM INTAKE; CALCIUM STONE; CLINICAL TRIAL; DIARRHEA; DISEASE ASSOCIATION; FLUID INTAKE; HUMAN; HYPERCALCIURIA; HYPEROXALURIA; HYPERURICOSURIA; NAUSEA; NEPHROLITHIASIS; PRIORITY JOURNAL; RASH; REVIEW; UNSPECIFIED SIDE EFFECT; URIC ACID BLOOD LEVEL;

EID: 33846961736     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2006.00723.x     Document Type: Review

References (34)

1. Ahlstrand C, Tiselius HG. Recurrences during a 10-year follow-up after first renal stone episode. Urol. Res. 1990; 18: 397-9.
2. Ljunghall S, Danielson BG. A prospective study of renal stone recurrences. Br. J. Urol. 1984; 56: 122-4.
3. Trinchieri A, Ostini F, Nespoli R et al. A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J. Urol. 1999; 162: 27-30.
4. Curhan GC, Willett WC, Rimm EB et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N. Engl. J. Med. 1993; 328: 833-8.
5. Taylor EN, Stampfer MS, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of followup. J. Am. Soc. Nophrol. 2004; 15: 3225-32.
6. Strauss AL, Coe FL, Deutsch L et al. Factors that predict relapse of calcium nephrolithiasis during treatment: A prospective study. Am. J. Med. 1982; 72: 17-24.
7. Tiselius HG, Sandvall K. How are urine composition and stone disease affected by therapeutic measures at an outpatient stone clinic? Eur. Urol. 1990; 17: 206-12.
8. Borghi L, Meschi T, Amato F et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: A 5-year randomized prospective study. J. Urol. 1996; 155: 839-43.
9. Curhan GC, Willett WC, Speizer FE et al. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int. 2001; 59: 2290-98.
10. Cirillo M, Stellato D, Panarelli P et al. Cross-sectional and prospective data on urinary calcium and urinary stone disease. Kidney Int. 2003; 63: 2200-206.
11. Leonetti F, Dussol B, Berthezene P et al. Dietary and urinary risk factors for stones in idiopathic calcium stone formers compared with healthy subjects. Nephrol. Dial. Transplant. 1998; 13: 617-22.
12. Al Zahrani H, Norman RW, Thompson C et al. The dietary habits of idiopathic calcium stone-formers and normal control subjects. BJU Int. 2000; 85: 616-20.
13. Borghi L, Schianchi T, Meschi T et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N. Engl. J. Med. 2002; 346: 77-84.
14. Hiatt RA, Ettinger B, Caan B et al. Randomized controlled trial of a low animal protein, high fiber diet in the prevention of recurrent calcium oxalate kidney stones. Am. J. Epidemiol. 1996; 144: 25-33.
15. Borghi L, Meschi T, Guerra A et al. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J. Cardiovasc. Pharmacol. 1993; 22 (Suppl. 6): S78-86.
16. Brocks P, Dahl C, Wolf H et al. Do thiazides prevent recurrent idiopathic renal calcium stones? Lancet 1981; 2: 124-5.
17. Ettinger B, Citron JT, Livermore B et al. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J. Urol. 1988; 139: 679-84.
18. Fernandez-Rodriguez A, Arrabal Martin M, Garcia Ruiz MJ et al. Effect of thiazide therapy in the prophylaxis of calcium lithiasis. Arch. Esp. Urol. 2001; 54: 1047-54.
19. Laerum E, Larsen S. Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med. Scand. 1984; 215: 383-9.
20. Ohkawa M, Tokunaga S, Nakashima T et al. Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria. Br. J. Urol. 1992; 69: 571-6.
21. Pearle MS, Roehrborn CG, Pak CY. Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J. Endourol. 1999; 13: 679-85.
22. Scholz D, Schwille PO, Sigel A. Double-blind study with thiazide in recurrent calcium lithiasis. J. Urol. 1982; 128: 903-7.
23. Wilson DR, Strauss AL, Manuel MA. Comparison of medical treatments for the prevention of recurrent calcium nephrolithiasis. Urol. Res. 1984; 12: 39-40.
24. Meyer JL, Smith LH. Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors. Invest. Urol. 1975; 13: 36-9.
25. Pak CY. Citrate and renal calculi: An update. Miner Electrolyte Metab. 1994; 20: 371-7.
26. Barcelo P, Wuhl O, Servitge E et al. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J. Urol. 1993; 150: 1761-4.
27. Ettinger B, Pak CY, Citron JT et al. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J. Urol. 1997; 158: 2069-73.
28. Hofbauer J, Hobarth K, Szabo N et al. Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis - a prospective randomized study. Br. J. Urol. 1994; 73: 362-5.
29. Soygur T, Akbay A, Kupeli S. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: A randomized controlled trial. J. Endourol. 2002; 16: 149-52.
30. Finlayson B, Newman RC, Hunter PT. The role of urate and allopurinol in stone disease: A review. In: Schwille PO, Smith LH, Robertson WG (eds). Urolithiasis and Related Clinical Research. New York: Plenum Press, 1985; 517-19.
31. Ettinger B, Tang A, Citron JT et al. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N. Engl. J. Med. 1986; 315: 1386-9.
32. Smith MJ. Placebo versus allopurinol for renal calculi. J. Urol. 1977; 117: 690-92.
33. Johansson G, Backman U, Danielson BG et al. Magnesium metabolism in renal stone formers. Effects of therapy with magnesium hydroxide. Scand. J. Urol. Nephrol. Suppl. 1980; 53: 125-34.
34. Ettinger B. Recurrent nephrolithiasis: Natural history and effect of phosphate therapy. A double-blind controlled study. Am. J. Med. 1976; 61: 200-206.